$39.000
+0.082 (+0.21%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
IX Prediction & Forecast by Similar Chart Analysis
Alphio's IX stock price prediction model matches the current ORIX Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $39.19 (+0.50%). The 1-week path is $39.34 (+0.87%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy ORIX Corp Stock?
Orix Corp is a good buy right now due to its strong revenue growth and favorable valuation metrics. The current price is $39.00, with a forward P/E of 14.245, indicating potential for earnings growth. Additionally, the year-to-date change is +32.25%, showcasing strong performance. However, the net margin has decreased to 6.82%, which is a risk to consider.
IX stock price ended at $39.00 on Friday, after rising +0.21%
ORIX Corp (IX) last closed at $39, gaining +0.21%. These facts feed the 1-day and 1-week IX price prediction above.
Analyst Consensus
ORIX Corp (IX): 1 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
ORIX Corp (IX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches IX, ranked by similarity.
Seasonality analysis for IX
Historically the probability of a positive August return for IX is 100.00%. July offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.